Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

566 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.
Rupp C, Rössler A, Zhou T, Rauber C, Friedrich K, Wannhoff A, Weiss KH, Sauer P, Schirmacher P, Süsal C, Stremmel W, Gotthardt DN. Rupp C, et al. Among authors: Sauer P. United European Gastroenterol J. 2018 Mar;6(2):255-262. doi: 10.1177/2050640617717156. Epub 2017 Jun 17. United European Gastroenterol J. 2018. PMID: 29511555 Free PMC article.
The proportion of females was significantly higher among patients with late-onset PSC (48.4 vs. 27.3%; p = 0.02). Patients with later diagnosis required dilatation therapy more often due to dominant stenosis (84.2 vs. 53.1%; p = 0.01) and suffered from recurrent cho …
The proportion of females was significantly higher among patients with late-onset PSC (48.4 vs. 27.3%; p = 0.02). Patients with later …
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study.
Stiehl A, Rudolph G, Sauer P, Benz C, Stremmel W, Walker S, Theilmann L. Stiehl A, et al. Among authors: Sauer P. J Hepatol. 1997 Mar;26(3):560-6. doi: 10.1016/s0168-8278(97)80421-7. J Hepatol. 1997. PMID: 9075663 Clinical Trial.
The actuarial Kaplan-Meier survival probabilities without liver transplantation after treatment with ursodeoxycholic acid and dilation of major duct stenoses were significantly improved compared to the predicted survival rates with p=0.001. ...
The actuarial Kaplan-Meier survival probabilities without liver transplantation after treatment with ursodeoxycholic acid and dilation of ma …
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.
Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Sauer P, et al. Gastroenterology. 1997 Nov;113(5):1623-31. doi: 10.1053/gast.1997.v113.pm9352865. Gastroenterology. 1997. PMID: 9352865 Clinical Trial.
Cumulative rates of rebleeding were 23% in the TIPS group and 57% in the ES group (P = 0.0001). Hepatic encephalopathy was observed in 29% of the patients in the TIPS group and in 13% of those in the ES group (P = 0.041). Cumulative rates of survival were 69% in the …
Cumulative rates of rebleeding were 23% in the TIPS group and 57% in the ES group (P = 0.0001). Hepatic encephalopathy was observed i …
Mechanism of hepatoprotective action of bile salts in liver disease.
Stiehl A, Benz C, Sauer P. Stiehl A, et al. Among authors: Sauer P. Gastroenterol Clin North Am. 1999 Mar;28(1):195-209, viii. doi: 10.1016/s0889-8553(05)70050-9. Gastroenterol Clin North Am. 1999. PMID: 10198785 Review.
Primary sclerosing cholangitis.
Stiehl A, Benz C, Sauer P. Stiehl A, et al. Among authors: Sauer P. Can J Gastroenterol. 2000 Apr;14(4):311-5. doi: 10.1155/2000/983681. Can J Gastroenterol. 2000. PMID: 10799084 Review.
[Therapy of primary sclerosing cholangitis].
Stiehl A, Benz C, Sauer P. Stiehl A, et al. Among authors: Sauer P. Praxis (Bern 1994). 2000 May 31;89(22):975-7. Praxis (Bern 1994). 2000. PMID: 10893998 German.
566 results
Jump to page
Feedback